Media coverage
1
Media coverage
Title Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION Degree of recognition International Media name/outlet Bio Med Central Media type Other Date 19/08/2022 Producer/Author Jan Kloka1†, Benjamin Friedrichson1†, Stephanie Dauth2,3, Ann Christina Foldenauer2, Anita Bulczak‐Schadendorf2, Maria J. G. T. Vehreschild4, Francisco Maio Matos5, Antoni Riera‐Mestre6,7,8, Antoinette D. I. van Asselt9, Edoardo De Robertis10, Vilma Traskaite Juskeviciene11, Patrick Meybohm12, Dana Tomescu13, Karine Lacombe14, Coen D. A. Stehouwer15,16, Kai Zacharowski1* and on behalf of the IXION Collaboration Group URL trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06609-x Persons René van Hulst